Cognitive-Behavioral Therapy for Children With Nightmares

Description

The goal of this clinical trial is to assess the efficacy of CBT-NC intervention to determine its impact on mental health and suicidality in children ages 6-17. The main aims are: Aim 1: Examine CBT-NC efficacy for improving nightmare distress and frequency in youth with chronic nightmares by comparing the treatment and waitlist group. Aim 2: Examine whether improvements in nightmares relate to fewer mental health problems for youth by determining by comparing the treatment and waitlist group.

Conditions

Nightmare, Suicidal Ideation, Children, Only

Talk to us

Study Overview

On this page

Study Details

Study overview

The goal of this clinical trial is to assess the efficacy of CBT-NC intervention to determine its impact on mental health and suicidality in children ages 6-17. The main aims are: Aim 1: Examine CBT-NC efficacy for improving nightmare distress and frequency in youth with chronic nightmares by comparing the treatment and waitlist group. Aim 2: Examine whether improvements in nightmares relate to fewer mental health problems for youth by determining by comparing the treatment and waitlist group.

Can a Brief Therapy Improve Pediatric Nightmares, Mental Health, and Suicidality?

Cognitive-Behavioral Therapy for Children With Nightmares

Condition
Nightmare
Intervention / Treatment

-

Contacts and Locations

Tulsa

University of Tulsa, Tulsa, Oklahoma, United States, 74104

Tulsa

University of Oklahoma School of Community Medicine, Tulsa, Oklahoma, United States, 74135

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

For general information about clinical research, read Learn About Studies.

Eligibility Criteria

  • * Child must be between ages of 6-17 years 11 months.
  • * Child must report recurrent nightmares that meet Diagnostic and Statistical Manual of Mental Disorders criteria for nightmare disorder.
  • * Child must speak and understand English at no less than a 6-year-old level.
  • * Children on prescribed psychotropic medications must be stable for 30 days prior to enrolling.
  • * Child must have a parent or legal guardian attend study visits with them.
  • * Participants must have access to WIFI/phone data in order to participate in this study and must have an electronic device with a camera enabled.
  • * Children with a diagnosis of sleep apnea which is not adequately treated.
  • * Children whose receptive/expressive language skills are below a 6-year-old level.
  • * If it is determined that a child is actively suicidal and at imminent risk for self-harm, the family will be notified and referred for immediate care. They will not be eligible for the study until they are deemed stable.

Ages Eligible for Study

6 Years to 17 Years

Sexes Eligible for Study

ALL

Accepts Healthy Volunteers

No

Collaborators and Investigators

University of Oklahoma,

Lisa Cromer, PhD, PRINCIPAL_INVESTIGATOR, University of Tulsa

Tara Buck, MD, PRINCIPAL_INVESTIGATOR, University of Oklahoma

Study Record Dates

2026-01-01